Pre-T-cell antigen receptor alpha chain (PTCRA)

The Pre-T-cell antigen receptor alpha chain (PTCRA), also known as pTalpha, is a transmembrane glycoprotein that serves as a surrogate for the TCR alpha chain during early T-cell development (UniProt, Q6ISU1). It forms a heterodimer with a rearranged TCR beta chain to create the pre-T-cell receptor (pre-TCR) complex, which is essential for the survival and expansion of immature thymocytes (NCBI Gene, 171558). Signaling through the pre-TCR complex drives the transition from the double-negative (DN) to the double-positive (DP) stage and ensures allelic exclusion of the TCR beta locus (PubMed, 10805110). Because PTCRA expression is restricted to early lymphoid precursors and is absent in mature T-cells, it is a highly specific marker for T-cell lineage commitment. In pathology, PTCRA is frequently overexpressed in T-cell acute lymphoblastic leukemia (T-ALL), where it may contribute to leukemogenesis by promoting constitutive proliferative signaling (Blood, 2002). Consequently, PTCRA is being investigated as a therapeutic target for T-ALL, with experimental strategies including monoclonal antibodies and CAR-T cell therapies designed to selectively eliminate malignant cells while sparing mature T-cell populations (Journal of Experimental Medicine, 2017). This restricted expression profile makes it an attractive target for minimizing systemic immunosuppression compared to pan-T-cell targets.

Other names

pT-alphaPre-TCR-alphaPTCRAPre-T-cell receptor alpha

Targeted depletion of pre-TCR expressing cells via antibody-dependent cellular cytotoxicity (ADCC) or chimeric antigen receptor (CAR) mediated lysis, and potential modulation of pre-TCR signaling pathways.